Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomePreferred Dividend PaymentsProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Benitec Biopharma (BNTC) EPS (Basic) (2019 - 2025)

Historic EPS (Basic) for Benitec Biopharma (BNTC) over the last 7 years, with Q2 2025 value amounting to -$0.21.

  • Benitec Biopharma's EPS (Basic) fell 9090.91% to -$0.21 in Q2 2025 from the same period last year, while for Jun 2025 it was -$1.03, marking a year-over-year increase of 8291.87%. This contributed to the annual value of -$1.05 for FY2025, which is 1393.44% up from last year.
  • Benitec Biopharma's EPS (Basic) amounted to -$0.21 in Q2 2025, which was down 9090.91% from -$0.38 recorded in Q1 2025.
  • In the past 5 years, Benitec Biopharma's EPS (Basic) registered a high of -$0.11 during Q2 2024, and its lowest value of -$9.88 during Q2 2022.
  • For the 5-year period, Benitec Biopharma's EPS (Basic) averaged around -$2.05, with its median value being -$0.72 (2021).
  • As far as peak fluctuations go, Benitec Biopharma's EPS (Basic) tumbled by 118709.68% in 2022, and later skyrocketed by 9584.91% in 2024.
  • Quarter analysis of 5 years shows Benitec Biopharma's EPS (Basic) stood at -$0.59 in 2021, then crashed by 466.1% to -$3.34 in 2022, then rose by 20.96% to -$2.64 in 2023, then soared by 90.15% to -$0.26 in 2024, then increased by 19.23% to -$0.21 in 2025.
  • Its EPS (Basic) stands at -$0.21 for Q2 2025, versus -$0.38 for Q1 2025 and -$0.26 for Q4 2024.